Lantheus Holdings Inc (NASDAQ:LNTH)
| 13.54 Delayed Data As of Aug 12 |  -0.15 / -1.10%Today’s Change | 8.67 Today|||52-Week Range 27.12 | -33.98% Year-to-Date |
Latest LNTH News | Press Releases
| FDA OKs Lantheus ultrasound imaging agent Aug 12 / Seeking Alpha - Paid Partner Content | Lantheus EPS beats by $0.02, beats on revenue Jul 30 / Seeking Alpha - Paid Partner Content |
| Lantheus Holdings, Inc.'s (LNTH) CEO Mary Anne Heino on Q2 2020 Results - Earnings Call Transcript Jul 31 / Seeking Alpha - Paid Partner Content | Notable earnings before Thursday's open Jul 29 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 13.68 |
| Today’s open | 13.79 |
| Day’s range | 13.43 - 13.86 |
| Volume | 488,575 |
| Average volume (3 months) | 628,572 |
| Market cap | $841.8M |
Data as of 3:59pm ET, 08/12/2020
Growth & Valuation
| Earnings growth (last year) | -23.36% |
| Earnings growth (this year) | -63.53% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +1.15% |
| P/E ratio | 46.7 |
| Price/Sales | 2.37 |
| Price/Book | 4.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MYGNMyriad Genetics Inc | +0.64 | +5.15% |
| AXDXAccelerate Diagnosti... | -0.16 | -1.08% |
| VIVOMeridian Bioscience ... | -0.02 | -0.11% |
| TRILTrillium Therapeutic... | +0.01 | +0.12% |
Data as of 3:59pm ET, 08/12/2020
Financials
| Next reporting date | November 3, 2020 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $347.3M |
| Annual profit (last year) | $31.7M |
| Net profit margin | 9.12% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters North Billerica, Massachusetts |
Forecasts
